- SEK2.38bn
- SEK2.09bn
- SEK627.69m
- 80
- 14
- 41
- 38
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 113.8 | ||
PEG Ratio (f) | 5.13 | ||
EPS Growth (f) | 28.48% | ||
Dividend Yield (f) | 0.71% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.67 | ||
Price to Tang. Book | 3.32 | ||
Price to Free Cashflow | 53.7 | ||
Price to Sales | 3.92 | ||
EV to EBITDA | 25.45 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -0.97% | ||
Return on Equity | -0.04% | ||
Operating Margin | -2.35% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | 626.19 | 717.16 | 658.18 | 618.28 | 627.69 | 663 | 709 | 0.77% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +1.28 | +7.92 | -10.3 | -51.14 | -58.6 | -9.22 | +108.21 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Directors
- Jean-Yves Parisot CHM (57)
- Tom Roennlund CEO (48)
- Henrik Lundkvist CFO (43)
- Andy McShea VOP (50)
- Shane Judge VPR (52)
- Basudha Bhattarai-Johansson VPR (37)
- Jorn Andreas IND (40)
- Irene Corthesy Malnoe IND (62)
- Charlotte Hansson IND (59)
- Malin Ruijsenaars IND (50)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- January 31st, 1991
- Public Since
- January 1st, 1998
- No. of Shareholders
- 3,430
- No. of Employees
- 167
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 11,394,125
- Address
- Ideongatan 1A, LUND, 223 70
- Web
- https://probi.com/
- Phone
- +46 462868920
- Contact
- Per Lindblad
- Auditors
- Ernst & Young AB
Upcoming Events for PROB
Dividend For PROB.ST - 1.3000 SEK
Q2 2024 Probi AB Earnings Release
Q3 2024 Probi AB Earnings Release
Similar to PROB
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Calliditas Therapeutics AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cline Scientific AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:17 UTC, shares in Probi AB are trading at SEK209.00. This share price information is delayed by 15 minutes.
Shares in Probi AB last closed at SEK209.00 and the price had moved by +12.37% over the past 365 days. In terms of relative price strength the Probi AB share price has outperformed the FTSE Global All Cap Index by +3.24% over the past year.
There is no consensus recommendation for this security.
The Probi AB dividend yield is 0.62% based on the trailing twelve month period.
Last year, Probi AB paid a total dividend of SEK1.30, and it currently has a trailing dividend yield of 0.62%.Looking ahead, shares in Probi AB are due to go ex-dividend on 2024-05-08 and the next dividend pay date is 2024-05-15.
Probi AB are due to go ex-dividend on 2024-05-08 and the next dividend pay date is 2024-05-15. The historic dividend yield on Probi AB shares is currently 0.62%.
To buy shares in Probi AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK209.00, shares in Probi AB had a market capitalisation of SEK2.38bn.
Here are the trading details for Probi AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: PROB
Based on an overall assessment of its quality, value and momentum Probi AB is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Probi AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -9.69%.
As of the last closing price of SEK209.00, shares in Probi AB were trading +4.35% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Probi AB PE ratio based on its reported earnings over the past 12 months is 113.8. The shares last closed at SEK209.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Probi AB's management team is headed by:
- Jean-Yves Parisot - CHM
- Tom Roennlund - CEO
- Henrik Lundkvist - CFO
- Andy McShea - VOP
- Shane Judge - VPR
- Basudha Bhattarai-Johansson - VPR
- Jorn Andreas - IND
- Irene Corthesy Malnoe - IND
- Charlotte Hansson - IND
- Malin Ruijsenaars - IND